Familial hypercholesterolemia: Diagnosis and management
Prof. Frederick Raal describes the prevalence and phenotypic variability of FH. Novel therapies have changed FH from a lethal disorder to a manageable dyslipidaemia.
Video navigation menu
- Phenotypic variability in FH 00:54
- Current/emerging therapies for severe FH 01:49
- LDL-c reduction with PCSK9 inhibitors in HeFH/HoFH 02:29
- Future perspectives for severe HoFH 04:03
Professor Frederick Raal is Professor and Head of the Division of Endocrinology and Metabolism at the University of the Witwatersrand, Johannesburg, South Africa.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme. PACE-cme did not receive financial support for the production of this recording.